The largest database of trusted experimental protocols

Hek 293a

Manufactured by Merck Group

The HEK 293a is a laboratory cell line derived from human embryonic kidney cells. It is commonly used in cell culture research and experimentation due to its reliable growth characteristics and ease of transfection. The HEK 293a cell line provides a standardized model for a variety of in vitro studies.

Automatically generated - may contain errors

2 protocols using hek 293a

1

Fluorescence-based Ligand Uptake Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A subclone of HEK 293 cells, called HEK 293a, originally obtained from Sigma-Aldrich was used in these experiments, either as a non-transfected cell type or as one stably expressing myc-tagged human B2Rs [8 (link)]. These cells were grown in Dulbecco’s modified Eagle’s medium supplemented with 10 % fetal bovine serum, 1 % l-glutamine, and 1 % penicillin–streptomycin stock solutions (100×). Cells were detached using the protease-free Cell Dissociation Buffer (Invitrogen), incubated in D-MEM without serum at 37 °C for 30 min under agitation in the presence of a Cy7-conjugated ligands and other drugs, rapidly centrifuged (30 s, 11,000g) and resuspended in phosphate buffered saline. Then, the fluorescence of the cell suspensions was assessed using the BD SORP LSR II cell analyzer for the uptake of the as a function of stimulation and transgene expression. The cytofluorometry results were analyzed using the BD FACS DIVA software.
+ Open protocol
+ Expand
2

CRISPR-Cas9 Mediated LRRC8A Knockout in HEK293A Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293A cells (Invitrogen) and LRRC8A-knockout HEK293A cells were cultured in DMEM-high glucose (Sigma-Aldrich, Cat. #D5671), supplemented with 10% fetal bovine serum (FBS; BioWest, Cat. #S1560-500) and 100 units/ml penicillin G (Meiji Seika, Cat. #6111400D2039). All cells were cultured in a 5% CO 2 atmosphere at 37ºC and verified to be negative for mycoplasma. LRRC8A-knockout HEK293A cells were established using the CRISPR-Cas9 system 39 . Briefly, the targeting sequence for human LRRC8A, 5′-GCACAACATCAAGTTCGACGTGG-3′, was designed using the CRISPR design tool (http://crispr.mit.edu/), and oligo DNAs for its sense and anti-sense were purchased from Bethyl Laboratories, MBL, and Sigma-Aldrich, respectively.
HRP-conjugated secondary antibodies against rabbit IgG (Cat. #7074, 1:2,000) and mouse IgG (Cat. #7076, 1:10,000-1:20,000) were purchased from Cell Signaling Technology.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!